Table 1.
Patients’ demographic and clinical data according to groups.
| AVR | TAVI | P | ||
|---|---|---|---|---|
| Age (mean±SD) | 71.43±1.25 (71) | 79.64±5.72 (81) | 0.001** | |
| EF (mean±SD) | 46.76±4.88 (45) | 46.96±4.97 (45) | 0.880 | |
| EuroSCORE (mean±SD) | 5.65±0.82 (5) | 9.75±1.27 (9) | 0.001** | |
| Gender n=number,% | Male | n=27 (52.9%) | n=11 (39.3%) | 0.354 |
| Female | n=24 (47.1%) | n=17 (60.7%) | ||
| DM number,% | (+) | n=36 (70.6%) | n=21 (75%) | 0.876 |
| (-) | n=15 (29.4%) | n=7 (25%) | ||
| HT number,% | (+) | n=45 (88.2%) | n=25 (89.3%) | 1,000 |
| (-) | n=6 (11.8%) | n=3 (10.7%) | ||
| Smoking number,% | (+) | n=30 (58.8%) | n=14 (50%) | 0.604 |
| (-) | n=21 (41.2%) | n=14 (50%) | ||
| NYHA number,% | II | n=7 (13.7%) | n=5 (17.9%) | 0.703 |
| III | n=39 (76.5%) | n=19 (67.9%) | ||
| IV | n=5 (9.8%) | n=4 (14.3%) |
AVR=aortic valve replacement; TAVI=transcatheter aortic valve implantation; EF=ejection fraction; HT=hypertension; DM=Diabetes Mellitus; NYHA=New York Heart Association;
SD=standard deviation **P<0.01